Redeye updates on Invisio following its Q1-results which were in line with our expectations.
InfraCom’s Q1 2024 report was mixed with net sales below Redeye Research estimates (RRe), while bett...
Ferronordic will report its Q1 results on 16 May. Taken together, we expect another challenging quar...
Relais' Q1 adjusted EBITA came in 13% above LSEG Data & Analytics consensus with a strong 12% y/y or...
Redeye remains positive towards Avensia following a Q1 report largely matching our forecasts.
Redeye sustains its positive view of CombinedX following a solid Q1 report.
80% of the ATH order book to be delivered within 12 months Higher opex to cut EBIT by 5-7% in 2024e-...
Redeye in this note comments Neonode’s Q1’24 and the last major news around the Aequitas lawsuit.
Q1 report due Wednesday 15 May at 07:00 CEST Q1e: sales EUR 44.
MGI’s Q124 report shows an impressive 21% organic revenue uplift over Q123, with both good new clien...
Today, Advenica recieved its third order for this quarter of SEK8.
En investering i Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) ger exponering...
Redeye provides a note following NeoDynamics’ Q1 2024 report.
Redeye provides an update on Scandinavian ChemoTech following the strong Q1 2024 report.
Redeye states that InfraCom's net sales was below expectations, and InfraCom states a tougher macro-...
Redeye updates its estimates following Arise’s Q1 report yesterday, which presented a solid set of n...
Redeye saw a sales development that was better than our expectations.
Suominen’s earnings recovery continues, although still at a somewhat slower pace than we had previou...
Aspo’s Q1 EBIT was soft relative to estimates, yet markets have now mostly stabilized; all three seg...
Marimekko reports its Q1/24 figures 15th of May. We expect flat sales year-on-year and slightly lowe...
